Participants
cancer, renal failure, hepatitis, Psychiatric
CHRONIC LUNG DISEASE, HEPATITIS, CHRONIC DISEASES
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Tsao-Tun Psychiatric Center, Ministry of Health and Welfare (protocol code IRB-10943 and date of approval 22-12-2020). A total of 92 older adults (aged 60 years and older) in central Taiwan were recruited for this study through their response to posters placed in communities within the northern Taiwan area. The subjects were tested using the non-random purposive sampling method. Potential participants were healthy adults who came to the hospital for their free NHS health check-up. All included participants provided signed informed consent as required by the Human Experiment Ethics Committee. Trials registered before the onset of patient enrollment at the Chinese Clinical Trial Registry (ChiCTR2100051573). The study was conducted at a community hospital, from September 2021 to December 2021. Generally healthy adults aged 60 and older with normal mobility were included; those with one or more chronic diseases (e.g., cancer, renal failure, hepatitis, chronic lung disease, etc.) were excluded.